Business · 05/10/2011

FDA Announces Review of Preemption Statements in Regulations

The Food and Drug Administration (FDA) has determined that three regulatory preambles contain statements about preemption that are not legally justified, following a review of its existing regulations issued over the past decade, in response to a 2009 presidential directive.